Kezar Life Sciences, Inc. (KZR)

NASDAQ: KZR · IEX Real-Time Price · USD

0.790

+0.002 (0.30%)

At close: Apr 19, 2024, 4:00 PM

0.800

+0.010 (1.24%)

After-hours: Apr 19, 2024, 4:37 PM EDT

Kezar Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	35.49	40.46	62.88	21.23	14.95	24.18	51.05
Short-Term Investments	165.88	236.11	145.47	119.22	63.26	83.25	0
Cash & Cash Equivalents	201.37	276.56	208.36	140.45	78.21	107.43	51.05
Cash Growth	-27.19%	32.74%	48.35%	79.59%	-27.20%	110.46%	-
Other Current Assets	5.58	9.16	3.3	4.36	2.93	2.37	1.28
Total Current Assets	206.95	285.72	211.65	144.81	81.13	109.81	52.33
Property, Plant & Equipment	8.69	13.17	6	6.75	8.1	4.6	1.54
Other Long-Term Assets	5.6	0.67	0.28	0.28	0.28	0.28	0.36
Total Long-Term Assets	14.29	13.85	6.28	7.03	8.38	4.88	1.9
Total Assets	221.24	299.57	217.93	151.84	89.51	114.68	54.22
Accounts Payable	8.25	2.48	2.03	2.36	0.82	0.19	0.55
Current Debt	3.01	2.57	1.2	1.04	0.9	0	0
Other Current Liabilities	6.48	5.95	4.99	3.04	4.28	3.14	0.94
Total Current Liabilities	17.74	11	8.21	6.44	6	3.34	1.48
Long-Term Debt	15.92	18.7	12.85	4.42	5.46	0	0
Other Long-Term Liabilities	0	0	0	0	0	2.55	0.49
Total Long-Term Liabilities	15.92	18.7	12.85	4.42	5.46	2.55	0.49
Total Liabilities	33.67	29.7	21.06	10.86	11.47	5.89	1.98
Total Debt	18.93	21.26	14.04	5.46	6.36	0	0
Debt Growth	-10.96%	51.41%	157.03%	-14.14%	-	-	-
Retained Earnings	-350.76	-248.89	-180.65	-126.02	-84.28	-49.2	-26.03
Comprehensive Income	-0.13	-0.92	-0.29	-0.14	-0.2	-0.2	-0.11
Shareholders' Equity	187.57	269.87	196.88	140.98	78.05	108.8	-25.69
Net Cash / Debt	182.44	255.3	194.31	134.98	71.84	107.43	51.05
Net Cash / Debt Growth	-28.54%	31.39%	43.95%	87.89%	-33.13%	110.46%	-
Net Cash Per Share	2.51	3.79	3.68	3.07	3.76	10.47	85.18
Working Capital	189.21	274.73	203.44	138.37	75.13	106.47	50.84
Book Value Per Share	2.58	4.01	3.73	3.20	4.09	10.60	-42.86

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).